From my understanding he's talking about "Issuance of KIT-302's clinical trial full study report".
Imo, it's not that critical when finished. He's just saying that in a prospectus they thought it would be done by end of July. Again, not critical because everything major is on time per ceo.
Basically you have preliminary findings and then you have full report which we probably already know 90% of findings.
I am hoping for a few new nuggets from the full report though. This could be released anytime.
Anyway, that is my understanding of this conversation